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Abstract 
Three triaza macrocyclic ligands, NOTP, NO2AP and NOA2P, and their gallium(III) 
chelates were studied in view of their potential interest as scintigraphic and PET imaging 
agents. A 1H, 31P and 71Ga multinuclear NMR study gave an insight on the structure, 
internal dynamics and stability of the chelates in aqueous solution. In particular, the 
analysis of 71Ga NMR spectra gave information on the symmetry of the Ga3+ coordination 
sphere and the stability of the chelates towards hydrolysis. The 31P NMR spectra afforded 
information on the protonation of the non-coordinated oxygen atoms from the pendant 
phosphonate groups and on the number of species in solution. The 1H NMR spectra 
allowed the analysis of the structure and the number of species in solution.  
31P and 1H NMR titrations combined with potentiometry afforded the measurement of the 
protonation constants (log KHi) and the microscopic protonation scheme of the triaza 
macrocyclic ligands. The remarkably high thermodynamic stability constant (log KGaL = 
34.44 (0.04) and stepwise protonation constants of Ga(NOA2P)2- were determined by 
potentiometry and 69Ga and 31P NMR titrations. Biodistribution and gamma imaging 
studies have been performed on Wistar rats using the radiolabeled 67Ga(NO2AP)- and 
67Ga(NOA2P)2-chelates, having both demonstrated to have renal excretion. The correlation 
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1. Introduction 
The importance of gallium chelates in nuclear medicine has led to an increasing interest in 
the coordination chemistry of this metal ion. The use of Ga3+ in clinical applications such as 
nuclear scintigraphy (67Ga; , t1/2 3.35 days) and particularly in positron emission 
tomography, PET, (68Ga; +, t1/2 68 min) is in rapid expansion [1-6]. Most of the67/68Ga 
radiopharmaceuticals belong to the class of gallium bioconjugates where a Ga3+ chelate is 
covalently linked to a biomolecule that is able to recognize a biological function, e.g. a 
receptor. High thermodynamic and kinetic stabilities are required for in vivo applications of 
the metal chelates, ensuring that the radiopharmaceutical remains intact during its lifetime 
in the body [7-9]. Triaza macrocyclic ligands are particularly appropriate to complex 
67/68Ga3+ due to their high conformational and size selectivities towards this metal ion 
allowing a proper fit of the relatively small cation in the triaza cavity [10]. 
The kinetics of complexation and dissociation processes, as well as the solution structures 
of the chelates are affected by the number and nature of the substituent groups bound to the 
nitrogen atoms of the macrocyclic ring. Ligands with different types of pendant arms 
(carboxylates [11-15], phosphinates [16-19] and phosphonates [20]) have shown to be very 
suitable ligands for Ga3+. 
The Ga3+ triaza chelates present symmetric crystal structures with the metal ion in a more or 
less distorted octahedral coordination polyhedron, showing a C3 symmetry axis. The three 
nitrogen atoms occupy one facial plane and the oxygen atoms from the pendant arms 
occupy the other almost parallel face (N3O3 systems). The degree of distortion of their 
crystal structures from regular octahedral coordination is defined by the relative twist angle 
(θ) of the N3 and O3 planes from the symmetrical staggered conformation. 69Ga and 71Ga 
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are quadrupolar nuclei and therefore the linewidths of the NMR signals they originate are 
determined by the electric field gradients present in the distorted Ga3+ coordination 
polyhedron. Thus the 69Ga and 71GaNMR signal linewidths can be used as a sensitive 
measure of that degree of distortion in solution [21]. 
In the continuation to our studies on the aqueous solution chemistry and structure of metal 
chelates of triaza-based ligands of potential interest for diagnostic purposes [14, 15, 20, 22-
25] we have performed a potentiometric and multinuclear (1H, 31P, 13C and 69/71Ga) NMR 
study of three triaza macrocyclic ligands differing in the number of carboxylate and 
phosphonate pendant arms (conferring varying overall charge to the chelates): H6NOTP 
(1,4,7-triazacyclononane-N,N´,N´´-trimethylene phosphonic acid), H4NO2AP (1,4,7-
triazacyclononane-N-methylenephosphonic acid-N´,N´´-dimethylenecarboxylic acid), and 
H5NOA2P (1,4,7-triazacyclononane-N,N´-bis(methylenephosphonic acid)-N´´- methylene 
carboxylic acid) (Fig.1) and of their Ga3+ chelates in aqueous solution. These studies 
include the determination of the stepwise protonation constants and microscopic 
protonation scheme of the ligands, as well as the  thermodynamic stability constant and 
protonation constants of Ga(NOA2P)2-. The conformation, dynamics and symmetry of the 
Ga3+ coordination sphere of the GaL chelates were studied by multinuclear NMR. Finally, 
to elucidate the influence of the charge and type of pendant arms (carboxylate versus 
phosphonate) on their in vivo properties, the behaviour of the 67Ga chelates of NO2AP4- and 
NOA2P5- was investigated by gamma-imaging and biodistribution studies in Wistar rats 
and was compared with our previous results on 67Ga(NOTP)3- [22]. 
 
2. Results and Discussion 
2.1. Determination of protonation and stability constants 
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The equilibrium reactions in the Ga3+ - L – H+ (where L denotes the multidentate ligand) 
ternary systems can be described by the following equations, where all the overall 
equilibrium constants (β) are concentration quotients rather than activities and are defined 
as: 






     (2) 
 
In the absence of Ga3+ (1) and (2) refer to the protonation equilibria of the ligands, and the 
respective constants are represented as log KHi. 
The protonation constants, log KHi, of the ligands NOTP and NOA2P as defined in equation 
(1) and (2), were determined by pH-potentiometric titrations at I = 0.1 M KCl and 25 ºC, 
except for log KH1, which was determined by 
31P NMR titration (see below), as its 
existence was proved by titrating the ligand in the presence of a large Ca2+ excess. The 
potentiometric titrations were performed in the pH range of 1.80-11.80 for the ligand (ESI 
Fig. S1) and 12.35-2.04 (see Fig. 2 as an example) since the formation of the Ga3+ 
complexes is fast under these conditions.  
Table 1 presents the calculated protonation constants based on potentiometry and 31P NMR 
 spectroscopy data, and compares them with values reported previously for NOTP [26] and  
NOTA [27-30]. The lowest constants (log KHn< 2) are close to the limit of potentiometry  
and they have higher uncertanties. The values of first constants (log KH1) for NOTP  
and NOA2P have been measured by 31P NMR (Fig. S2). It is worth noting that the 31P 
NMR chemical shift - pH curve of NOA2P (Fig. 3) shows a bell-shaped character in the pH 
= 1.8 - 10 range and cannot be fitted by the 4 protonation constants measured by 
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potentiometry. However, the chemical shift - pH data points (where pH = 14 + log CKOH, 
CKOH = 0.1-10) can be fitted by a value of log KH1 = 14.21 ± 0.09 (Fig. 3). This value is 
much higher than those obtained previously for NOTP by potentiometry in 0.1 M NaCl 
(11.7) or 0.1 M NMe4Cl (12.1) [26], indicating the competing effect of complex formation 
of the respective cations by the ligand on its protonation. In a previous study, it was 
observed that the 1H and 31P NMR pH titration curves obtained for NOTP in 0.1 M NMe4Cl 
had an inflexion at high pH, indicating a first ligand protonation at pH well above 12 [26]. 
It is well known that the substitution of methylenephosphonate groups on the nitrogen atom 
of the parent cyclic amine results in a large increase in the first protonation constant of the 
macrocyclic phosphonate ligands, with values well above 14.0, which can only be obtained 
by NMR pH titrations, as observed here for NOTP and NOA2P (with log KH1 around 
14.21, see Table 1) and by others for the tetraaza macrocyclic analogue DOTP (log KH1 = 
14.65) [31]. The effect of substituent methylenephosphonate groups on the protonation of a 
nitrogen site is much stronger than that of methylenecarboxylate groups, as seen by the 
much lower log KH1 value of NOTA (Table 1). The second protonation step, like the first 
one, also involves protonation of the macrocyclic ring nitrogens [26, 27].  The log KH2 
value is much higher for the phosphonate ligands NOTP and NOA2P than for the 
carboxylate ligand NOTA. This shows that the difference between the effects of the 
methylenephosphonate and acetate functionalities on the basicity of the nitrogen atoms in 
the monoprotonated form of the ligand is basically maintained, although the electrostatic 
and inductive effects of those substituent groups may be somewhat altered by the formation 
of intramolecular hydrogen bonds. Further protonation detected for NOTP and NOA2P 
occurs at the phosphonate and carboxylate pendant groups (Table 1). The sequence of 
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microscopic protonation sites of NOTP, NOA2P and NO2AP was further studied in detail 
by 1H NMR pH titrations and is discussed in the SI.  
The equilibrium reactions in the Ga3+ - L – H+ ternary system can also be described by 
equations (1) and (2), where i = 1,2,3 mean protonated complexes, while i = -1 or -2 means 
mixed hydroxo complexes. A detailed equilibrium study has been done for the NOA2P 
ligand. The triaza macrocyclic ligands are known to form very stable complexes with the 
Ga3+ ion. The formation of the GaL or HxGaL species is often complete in very acidic 
solution (pH ≤ 2), therefore pH-potentiometry based on H+ - metal ion competition is not 
suitable to measure the thermodynamic stability constant. An additional serious technical 
problem is related to the slow formation of complexes in acidic solutions, [32] which 
requires a long time for equilibration, i.e. direct potentiometry cannot be used, and 
preparation of separated samples and long waiting times are needed to measure stability 
constants. In some cases there is a definite need for combination with competition using 
secondary ligands and/or metal ions. Fortunately, gallium is an amphotheric element and 
the Ga3+ ion forms very stable complexes with OH–, i.e. one can use the hydroxide as a 
competitor ligand in the alkaline region. An additional advantage of the high pH is that the 
complex formation is likely quite fast at pH ≥ 8, therefore we could use direct 
potentiometry titration in the Ga3+ – NOA2P5- – H+ system from pH = 12.6 to pH = 8 to 
evaluate the stability constant(s) with relatively short waiting time for equilibrium. 
Following the titration of the already equilibrated system from pH = 8 to 1.8 one can get 
the protonation constants of the HxGaL species without any dissociation of the complexes. 
The stability constants are summarized in Table 2 together with data for several Ga3+ 
complexes for comparison. 
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The thermodynamic stability constant of Ga(NOA2P)2- (log βGaL= 34.44) is much higher 
than the previously reported values for Ga(NOTA) [19] and Ga(DOTA)[32]. The higher 
value relative to Ga(NOTA) could be partially ascribed to the higher overall basicity of 
NOA2P relative to NOTA due to the presence of the two methylenephosphonate groups. 
The size of the triaza macrocyclic ring matches that of the Ga3+ion (r = 0.68 Å) quite well, 
but, as the ring occupies only one facial plane of the coordination octahedron, such a 
matching might play a minor role in complex stability. The ability of Ga3+ to promote the 
distortion of the macrocyclic ring to allow the pendant groups to come to the ideal 
structural proximity to the metal centre for bond formation could be the determining factor 
in stabilizing the complex. As the phosphonate ligands are more rigid than the carboxylate 
ones, as shown by NMR (see later), they can more easily adopt a pre-organized 
conformation favourable to bond formation, leading to an entropic contribution to the 
stability of the Ga(NOA2P)2- complex. In the case of Ga(DOTA), stability decreases due to 
a larger macrocyclic ring and the presence of two free carboxylate groups [32].  
The stability sequence of the NOTA analogues based just on their resistance against the 
formation of Ga(OH)4
-, as followed by 71Ga NMR, will be discussed below. 
Three protonation steps were found for the Ga(NOA2P)2- complex, the first two 
corresponding to protonation of the negatively charged metal-unbound oxygen atoms of the 
two coordinated phosphonate groups, while the third one probably results from protonation 
of the carboxylate. Despite the tendency of Ga3+ to form hydroxocomplexes, two mixed 
hydroxocomplexes were considered in the potentiometric model. In these hydroxospecies, 
the hydroxide anion probably replaces one or two of the coordinated pendant arms. An 
hydroxo complex was previously proposed for Ga(NOTA) [19] but not for Ga(DOTA) 
[32].  
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As it is difficult to compare the stability constants of different Ga3+ chelators due to 
differences in ligand pKa and/or stoichiometry, the pGa value has been proposed as a means 
for more direct comparison. The pGa values express the amount of free Ga3+ present at 
equilibrium at a total ligand concentration of 10−5 M, a total Ga concentration of 10−6 M, 
and pH 7.4. A pGa = 26.60 was calculated for Ga(NOA2P) from our thermodynamic data 
in Table 2, which is higher than that of Ga(NOTA) (pGa = 24.81) and specially of 
Ga(DOTA) (pGa = 20.19), indicating that NOA2P is the strongest chelator.   
2.2. NMR studies of the complexes. In order to validate the speciation model of the Ga3+ - 
NOA2P – H+ ternary system based on potentiometry, we have carried out 31P and 69Ga (I = 
3/2, 60.4 % natural abundance, quadrupole moment Q = + 17.8 fm2 (1 fm = 10-15 m)[33]) 
NMR measurements in strongly alkaline samples (Fig. 4). In fact, the following reaction 
has been followed: 
Ga(NOA2P)(OH)3-  +   2OH-  + H2O      Ga(OH)4
-   +    HNOA2P4-   (3)         
The free ligand (NOA2P5- dominantly in monoprotonated form) gives a (proton coupled) 
31P NMR triplet signal at 10.9 ppm, while the Ga(NOA2P)(OH)3- shows two partially 
overlapping signals at 11.45 and 11.60 ppm. Despite the limited resolution, one can clearly 
conclude the non-equivalence of the two coordinated phosphonate groups in the 
Ga(NOA2P(OH))3-  complex. The 69Ga NMR spectra are in full agreement with the 31P 
NMR results, and although the signal of Ga(NOA2P)(OH)3- at about 120 ppm is too broad 
for quantitative integration, the sharp signal of Ga(OH)4
- at 220 ppm gives reliable intensity 
data for calculation of the molar ratios. Fig. 5 shows the distribution curves calculated by 
the potentiometric model together with the concentrations of the species measured by 
multinuclear NMR. The coincidences are in general very good, with a small systematic 
deviation at the highest pH values. 
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The behaviour in aqueous solution of the Ga3+ complexes of the three phosphonate-
containing ligands, NOTP6-, NO2AP4- and NOA2P5- (Fig. 1) was further studied by 69/71Ga, 
31P, 13C and 1H multinuclear NMR spectroscopy. Table 3 summarises the observed 71Ga (I 
= 3/2, 39.6 % natural abundance, quadrupole moment Q = 11.2 fm2 [33]) NMR data 
obtained for these systems, together with that previously reported for other triaza 
macrocyclic ligand complexes. In our previous studies with Ga(NOTP)3- a 71Ga NMR 
signal was detected at 110 ppm (Δν1/2 = 434 Hz) and the chelate was found to be stable 
towards acid and base catalysed hydrolysis in the pH range 2 – 8 [20]. In this pH interval, 
the signal of the Ga3+ aqua-ion was not observed. At pH above 8, the signal of Ga(OH)4
- ( 
= 222 ppm) could be detected, whereas its carboxylate analogue Ga(NOTA) only shows 
formation of tetrahydroxogallate above pH 10 and has a wider pH range of stability (pH 0.7 
to 12) [11,12]. The different stabilities of the NOTP6- and NOTA3- chelates against 
hydroxide attack might arise from a more open bite angle N-Ga-O, due to larger P-C and P-
O bonds in the former than C-O and C-N in the later [20]. 
The 71Ga NMR shifts of Ga(NOTA) (171 ppm), Ga(NO2AP)- (153 ppm), Ga(NOA2P)2- 
(130 ppm) and Ga(NOTP)3- (110 ppm) show an almost linear variation with the number of 
phosphonate binding groups, which have an additive effect on the 71Ga shifts. Upon 
successive substitutions of carboxylate groups by phosphonate groups in Ga(NOTA), the 
71Ga shift decreases by similar amounts (28, 23 and 20 ppm), in agreement with empirical 
predictions based on the dependence of 71Ga shifts on the type and number of coordinated 
pendant groups (carboxylate > phosphinate ester > phosphonate [20]). These effects are 
much larger than those observed in triaza macrocyclic chelates where the Ga3+ coordination 
changes from N2O3 to N4O2 [25]. Such a reduction (although smaller) of the metal nucleus 
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shift upon replacement of carboxylate coordination by phosphonate coordination is also 
observed for 27Al NMR shifts, as exemplified by Al(NOTA) and Al(NOTP)3- (Table 3). 
The 71Ga shifts of the Ga3+ chelates are almost constant for pH 5-10, where the 
unprotonated complexes predominate (data not shown). However, the formation of 
protonated forms at lower pH values and of the hydroxo complexes at pH > 10, 
significantly affect the shifts.  
The linewidth of the 71Ga NMR resonance is very sensitive to the symmetry of the Ga3+ 
coordination sphere. The signals of Ga(NO2AP)- and Ga(NOA2P)2- are much broader than 
those found previously for Ga(NOTP)3- [20] and specially for Ga(NOTA) [11, 12], 
reflecting a more distorted octahedral geometry. Ga(NOTA) has a highly symmetric crystal 
structure, with Ga3+ in a slightly distorted octahedral coordination polyhedron, with two 
opposite almost parallel faces N3 (formed by the three ring nitrogen atoms) and O3 (from 
the pendant carboxylate oxygen atoms) [11, 12]. The degree of distortion of this 
coordination polyhedron from a regular octahedron is defined by the twist angle θ between 
the N3 and O3 planes from the symmetrical staggered conformation, which can be estimated 
to be higher in the phosphonate complexes than for Ga(NOTA) (θ = 12.4 o) [11, 12]. The 
71Ga NMR signal linewidth is determined by quadrupolar relaxation, which increases with 
the electric field gradients caused by distortion of the Ga3+ coordination polyhedron. Thus, 
for complexes with approximately the same size (same rotational correlation time), the 71Ga 
linewidths are a sensitive measure of the degree of distortion of the complexes in solution. 
The 71Ga NMR linewidths available for a series of Ga3+ chelates of different triaza 
macrocycles suggest the following sequence for the degree of distortion in relation to a 
perfect octahedral geometry: Ga(NOTA) ~ Ga(NODASA) ~ Ga(NOTMP) < Ga(NOTP) < 
Ga(NOTPP) < Ga(NO2AP) < Ga(NOTBzP) < Ga(NOA2P) < Ga(DETA) << Ga(DOTRA) 
 12 
<< Ga(UNTA)[20]. The presence of bonds with different lengths in the case of 
Ga(NOA2P)2- and Ga(NO2AP)- (P-O longer than C-O) contributes to the symmetry 
distortion of the Ga3+ coordination polyhedron in these chelates and thus to the increase of 
the quadrupolar relaxation and concomitant signal broadening. 
The 31P NMR spectra of Ga(NO2AP)- and Ga(NOA2P)2- in aqueous solution exhibit only 
one signal in the pH range 2 – 10, with shifts at pH 7.0 of 13.80 and 14.90 ppm, 
respectively, which are lower than the value of 18.00 ppm reported for Ga(NOTP)3- at the 
same pH [22]. The ligands with more than one phosphonate group form Ga3+ complexes 
with magnetically equivalent bound phosphonates. Below pH 4, the 31P chemical shift 
increases as protonation of the non-coordinated negatively charged oxygen atoms of the 
metal-coordinated phosphonate groups occurs, in accordance with previous studies [22, 
26]. Above pH 10-12, the NMR signal of the free ligand also starts to appear (Fig. 7). 
The 1H, 13C and 2D NMR spectra of Ga(NOA2P)2-, as well as the 1D 1H spectrum of 
Ga(NO2AP)- at pH 7 are shown in Figures S8, S9 and S10, and should be compared  with 
those of Ga(NOTP)3- and Ga(NOTA) from the literature [11, 12, 20]. Their detailed 
analysis is described in the SI. Here only the main conclusions are highlighted. The type of 
proton spectrum obtained for these complexes depends on the NMR timescale of their 
internal conformational rearrangements, namely the concerted ()() 
conformational interconversions of the ethylene diamine protons in the five-membered 
chelates of the triaza ring, and the concerted interconversion of the three pendant arms 
between  and  configurations in the distorted coordination octahedron. Those processes 
have been found to be slow for Ga(NOTP)3-, with quite rigid macrocyclic rings [20], in 
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contrast with Ga(NOTA), with fast conformational exchange of the flexible ring. 
[11,12,15]. 
The 1H NMR spectrum of Ga(NOA2P)2- displays a complex pattern of signals (Fig. S8), 
reflecting a rigid complex with inert metal-ligand bonds. The internal conformational 
interconversions are slow on the NMR time scale, with no equivalence between the protons 
in axial and equatorial positions above and below the ring N3 plane. The two acetate 
protons form a sharp AB pattern, while the four phosphonate protons originate an ABX 
system due to coupling to X = 31P. All the ring protons are magnetically non-equivalent, 
leading to twelve different multiplets. The rigidity of the arms and ring of the complex is 
confirmed by its proton-decoupled 13C NMR spectrum (Fig. S8B). The acetate pendant arm 
originates a singlet for the C7,8 methylene carbon, while the two equivalent C7,8 
methylenephosphonate carbons resonate as a doublet due to geminal coupling to 31P. The 
six ring carbons are all magnetically non-equivalent. Of those, the four located next to the 
two phosphonate arms (C25u, C36d, C’36u and C’25d) can be distinguished by their different 
two-bond 13C-31P coupling constants. Those located above the N3 plane (C25u and C’36u)) 
are doublets, with 2JPC = 14 Hz, due to P-C-N-Cu dihedral angles close to 180º. Those 
below that plane (C36d and C’25d) are singlets, since the P-C-N-Cd dihedral angles are close 
to 90º and the coupling is too small to be observed (2JPC < 1 Hz) [16,36].  The other two 
carbons (C14d and C’14u) are also singlets, due to their distance from the 31P nuclei (4JPC < 1 
Hz).  
The 1H NMR spectrum of Ga(NO2AP)- (Fig. S10) shows an AB pattern for the four acetate 
protons and an ABX multiplet for the two methylenephosphonate protons, with broad 
resonances for the twelve macrocyclic ring protons, indicating that the ()↔() 
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conformational interconversions of the ring NCH2CH2N protons are fast on the 
1H NMR 
time scale.  
Thus, from the analysis of the NMR data available, it can be concluded that the presence of 
an increasing number of phosphonate groups in these Ga3+ complexes rigidifies their 
structure, a similar effect to what has been observed for Ln(DOTA), Ln(DO2A2P) and 
Ln(DOTP) complexes [36-39]. 
2.3. In vivo studies 
The properties of the two structurally related radio-chelates [67Ga](NO2AP)- and 
[67Ga](NOA2P)2- were evaluated in Wistar rats in vivo aiming at the elucidation of 
structure-activity relationships determinant for biodistribution and clearance from the body. 
The scintigraphic images obtained 30 minutes after injection of the 67Ga3+-labeled chelates 
are shown in Fig. S11. Both chelates show activity in the bladder and in the kidneys 
significantly higher than the background. Fig. S12 shows the averaged time-activity curves, 
obtained from dynamic acquisitions for regions of interest (ROI) in the kidneys and liver. 
The values of mean activity/pixel for each ROI, after background subtraction, stated as the 
thorax activity, have been used to obtain regional time-activity curves that were further 
normalized to the maximum activity obtained for each chelate. The imaging data confirm 
that both radio-chelates undergo renal excretion, as expected for highly charged species. 
The renal excretion curves for the two 67Ga3+ chelates are very similar indicating that the 
presence of an extra negative charge for [67Ga](NOA2P)2- does not change much its renal 
excretion profile. Furthermore, none of the chelates seems to be retained for a long time in 
the kidneys as the decrease of activity with time reveals. In a previous study, the 
structurally related [67Ga](NOTA), [67Ga](NOTPME) and [67Ga](NOTP)3- chelates were 
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found to undergo renal excretion, with a much longer kidney retention time for the high 
negatively charged (-3) chelate [67Ga](NOTP)3- than the neutral ones [22]. 
Fig. 6 shows the biodistribution results for the two radio-gallium chelates 2 h after 
injection. The activity is presented as percentage of the injected activity per gram of organ 
(%ID/g). These results show that the main activity is located in the kidneys, which is in 
good agreement with the scintigraphic imaging data. The percent kidney activity retained at 
2h for the two chelates with (-1) and (-2) charge is higher than the values observed in the 
same conditions for the neutral chelates [67Ga](NOTA) and 67Ga(NOTPME), but lower 
than for the (-3)  charged [67Ga](NOTP)3- chelate [22], indicating a positive correlation of 
chelate negative charge with its kidney retention. The activity measured for the other 
organs is negligible, particularly for the brain. The absence of activity in the brain indicates 
that these chelates are unable to cross the blood brain barrier, as expected for charged 
hydrophilic compounds. [40]  
These results demonstrate the high in vivo stability of these two 67Ga3+ chelates. Their 
dissociation would lead to the accumulation of the radio-metal in iron sites, such as 
transferrin, which accumulates in the bone marrow. [41] This is in agreement with the 
much higher conditional stability of Ga(NOA2P)2- relative to Ga-Transferrin (Ga2Tf). [42] 
Such a comparison is best done by comparing calculated pGa values (values of free Ga3+ 
computed for a 1 M Ga3+ and 10 M ligand solution at pH 7.4). Pecoraro reports the 
values of the two conditional stability constants (at 27 mM NaHCO3 and pH 7.4) for Ga
3+ 
binding to transferrin, log K*1 = 20.3 and log K*2 = 19.3, with the corresponding pGa 
values (of 21.3 and 20.3). Using the stability data of Table 2a much larger value of pGa = 
26.60 for Ga(NOA2P) can be calculated (assuming no NaHCO3 effect), also larger than for 
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Ga(NOTA) (pGa = 24.81), and specially Ga(DOTA) (pGa = 20.19) [19, 32]. In addition, 
chelate decomposition would lead to formation of gallium hydroxide colloids that would be 
trapped by the liver and spleen macrophages. These processes would originate considerable 
background activity during longer periods and slower excretion. The biodistribution data 
obtained 48 h after injection (data not shown) reinforces this conclusion, as there is 
virtually no activity located in the bones or at the liver-spleen level.  
3. Conclusions 
The protonation of the triaza macrocyclic ligands NOTP6-, NO2AP4- and NOA2P5- and 
their complexation by Ga3+ were investigated by potentiometry and multinuclear (1H, 31P, 
13C and 69/71Ga) NMR spectroscopy and were compared with previous results with NOTA3- 
and NOTP6-. We determined the ligand stepwise protonation constants by NMR, including 
the very high first one (log KLH1 >14) for NOTP
6- and NO2AP4-, which is outside the range 
of potentiometry. The high basicity of the chelators contributes to the slow formation 
kinetics of their Ga3+ chelates and the slow 67/68Ga radiolabeling, requiring heating at 95 ºC 
for 30 minutes. It has been previously proposed that during the formation of chelates with 
this kind of macrocycles the rigid ring acts simply as a frame, constraining the pendant 
arms of the ligand (either acetate or methylenephosphonate) to a rather rigid position, 
favourable for coordinating the M3+ ions [37]. All the studied chelates have shown a 
remarkable thermodynamic and kinetic stability in solution. However, their structural 
internal dynamics were found to be different. The higher rigidity of the NOTP6- chelate was 
particularly evident when compared with the NOTA3- chelate, which lead to the non-
equivalence of all the ring protons in the former complex. The NOA2P5- chelate shows a 
similar rigidity to the NOTP6- chelate, whereas the macrocyclic ring in the NO2AP4- chelate 
is as flexible as the ring in the NOTA complex. Thus, from the present studies of this series 
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of Ga3+ complexes, we observed a rigidifying effect of an increasing number of 
phosphonate groups on the ligand structure. 
In addition to their own steric requirements, the conformational characteristics of the 
macrocyclic ring in the chelated ligands are largely determined by the ionic radius of the 
metal ion. From this and other studies, the high preference of the triaza macrocycles for the 
Ga3+-ion is evident, a fact of great importance in the biomedical applications of these type 
of chelates. This is illustrated by the remarkably high thermodynamic stability constant of 
the Ga(NOA2P)2-  complex (log KGaL = 34.44), which was determined by a method based 
on the combined use of potentiometry and 69Ga and 31P NMR, as a case study. Its 
conditional stability at pH 7.4 is still considerably higher than the Ga3+-transferrin complex. 
The Ga(NOA2P)2-  chelate is also more stable than Ga(NOTA) and Ga(DOTA)- chelates, 
frequently used in bioconjugation.  
The multinuclear NMR data obtained for the GaL chelates allowed to obtain new insights 
into their conformational dynamics, in particular, the rigidifying effect of phosphonate vs. 
carboxylate Ga3+ chelation. 
The in vivo behaviour of the radiochelates 67Ga(NO2AP)- and 67Ga(NOA2P)2- in Wistar 
rats, as studied by gamma-imaging and biodistribution, proved their high in vivo stability 
and rapid renal excretion. Our studies also demonstrated how the biodistribution profile of 
small chelates can be tuned by the overall chelate charge, as the renal retention of the 
chelates increases with their negative charge.  
In conclusion, the presence of phosphonate binding groups increases the thermodynamic 
stability and rigidity of the Ga3+ triaza macrocyclic chelates, which are important features 
to take into account in the optimized design of   67/68Ga-radiolabeled bioconjugates for 
nuclear imaging. For instance, the single acetate arm of NOA2P could be conjugated to the 
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terminal amino group of a peptide, as shown before for Ga(NOTA)-RGD conjugates [24]. 
Ga3+-NODAGA analogues, similar to Ga3+-NODAGATOC, [43] with two 
methylenephospho(i)nate arms and the carboxylate group conjugated to a peptide, such as a 
c-RGD or an octreotide, could also be envisaged in future work 
 
4. Experimental section 
4.1. Materials 
The ligands H6NOTP [26,44], H4NO2AP and H5NOA2P [45] were synthesised according 
to the literature. The purity of these ligands was checked by 1H NMR spectroscopy, and 
their chemical shifts were in agreement with the values reported in the literature [26,44,45]. 
[67Ga](citrate) was purchased from CIS-BIO (Gif-sur-Yvette, France). All the other 
reagents and solvents were of analytical grade and were purchased from Sigma-Aldrich and 
were used without further purification. 
4.2. Potentiometry 
The potentiometric titrations were carried out with a Metrohm 702SM Titrino titration 
workstation with the use of a Metrohm-6.0233.100 combined electrode. The titrated 
solutions (6 - 10 mL in total) were thermostated at 25 ± 0.1 ºC. The samples were 
magnetically stirred and N2 gas was bubbled through the solutions before and during the 
procedure to avoid any interaction with air. The titrations were performed in the pH range 
of 12.35-2.04 (see Fig. 2). The ionic medium was 0.1 M KCl. The pH-electrode was 
calibrated using standard KH-phthalate (pH = 4.005) and borax (pH = 9.177) buffers. The 
H+ concentrations were calculated from the measured pH values according to the method 
proposed by Irving et al. [46]. 
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The concentration of the H5NOA2P ligand was determined by pH-potentiometry 
from the difference of the titration curves obtained in the absence and presence of 50-fold 
excess of Ca2+ (Fig. S1). The difference in the inflection points of the two titration curves 
corresponds to three equivalents of the ligand. The protonation constants of NOA2P5- were 
determined in 0.1 M KCl and were calculated from the potentiometric data obtained by 
titration of 6.00 mL solution containing of 4.715 mM ligand with a standardized carbonate-
free 0.1937 M KOH in the pH range 1.78-11.92. The titrations of the Ga3+ complex of 
NOA2P5- were performed with 4 mM ligand solutions containing 1 equivalent of the metal 
cation from pH 12.35 to 2.04, with maximum 5 min waiting between two consecutive 
titration points to get constant potential. The equilibrium constants were calculated from at 
least two parallel titrations with the program PSEQUAD [47]. The whole curve was fitted 
simultaneously and the equilibrium constants of the GaL(OH)2, GaL(OH), GaL and 
protonated species (L = NOA2P) were evaluated form the titration data.  The titrated 
sample was back titrated with base solution and the obtained curve (strong acid-base-like 
titration curve) suggests a slow equilibration process in this direction. Only mononuclear 
Ga3+-species were found. Fixed values were used for the ionic product of water at 25 ºC 
and 0.1 M ionic strength (determined by independent titration to be pKw = 13.89), ligand 
acidity constants, the hydrolysis constants of Ga(OH)n
+3-n species (n=1-4)[48] and total 
concentrations of metal, ligand and acid. All values and errors (one standard deviation) 
reported are at least the average of two consistent and independent experiments. 
 
4.3. NMR studies 
The NMR spectra were obtained on a Bruker Avance II 400 spectrometer operating at 
400.13 (1H), 121.99 (71Ga), 161.97 (31P) and 100.610 (13C) MHz, a Bruker AVANCE I 360 
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spectrometer operating at 360.13 (1H), 86.43 (69Ga, tuning the 13C channel of a QNP probe 
to the given frequency) and 145.78 MHz (31P, the advantage of this experimental setup was, 
that 69Ga and 31P spectra could be measured with the same probe on the same samples just 
changing between the 13C and 31P channels); and a Varian Unity-500 spectrometer 
operating at 499.84 (1H), 202.34 (31P) and 152.40 MHz (71Ga). The chemical shifts are 
reported in ppm, relative to the external references tetramethylsilane (TMS) for 1H, H3PO4 
(85% v/v) in D2O for 
31P and the signal of 0.1 M [Ga(H2O)6]
3+ in a solution of gallium 
nitrate in water containing 0.1 M HNO3  and 10% D2O for 
69/71Ga, respectively. 31P and 13C 
NMR spectra were measured with broad-band proton decoupling except for several spectra 
with no decoupling indicated in the text. The 1H and 13C NMR spectra were only partially 
assigned using the two-dimensional COSY, 1H-13C HSQC and 1H-13C HMBC techniques. 
The spectra were obtained in the temperature range of 20 to 80 °C and in the pH range of 
0.5 to 13. Some 1H and 31P NMR were recorded in highly alkaline solutions of 1-10 M 
KOH (i.e. out of range of the pH concept), where the pH = 14 + log CKOH. The experiments 
at variable temperature were run with a precision of ± 0.5 °C. 
The solutions of the ligands NOA2P, NO2AP and NOTP (10 mM) for 1H NMR pH 
titrations were prepared in D2O (99.8 %) and the pD was adjusted with DCl and CO2-free 
NaOD solutions. The final pH was determined with a Hanna 8417 pH meter fitted with a 
combined Hanna H11310 electrode.  For the D2O solutions, the measured pH value was 
corrected for the deuterium isotope effect according to pH = pD - 0.40. [49] 
The first pKa values of NOA2P and NOTP were determined at 25º C by 
31P NMR. The pH 
was adjusted by addition of cc. HCl and/or cc. KOH solution. Separate 10 mM solutions in 
water were prepared in the pH range of 12.2 – 15 and an insert capillary with 5 l 
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phosphoric acid and 495 l D2O as an external reference and for locking.  The pKa values 
were calculated by least square fitting of the experimental pH-chemical shift data pairs of 
the titration curves using the program Scientist. 
The speciation model based on pH-potentiometry for Ga3+ – NOA2P5- – H+ was also 
checked using 69Ga and 31P NMR. For this purpose, a linear calibration relationship was 
obtained between the measured intensity of the 69Ga NMR signal of the Ga(OH)4
- species 
present in a series of gallium nitrate aqueous solutions at pH 13 and concentrations in the 2 
– 15 mM range (Fig. S7). Then, a series of 10 mM solutions of the complex were prepared 
by mixing solutions of ligand and gallium nitrate at 1:1 molar ratio in the pH range 11.1 – 
13 and the intensities of their 69GaNMR signal of the Ga(OH)4
- species, as well as the 
integrals of their 31P NMR signals observed for the Ga(NOA2P)2- complex and free 
NOA2P ligand were measured, as shown in Fig. S4. The molar fractions of the species 
were calculated from the NMR intensities and plotted together with the distribution curves 
in order to visualise the matching of the results from the two independent sets of 
experiments (Fig. 5). 
The 1H, 31P and 71Ga NMR studies of the chelates on the Varian U-500 spectrometer were 
carried out in D2O (99.8 %) at 10 mM concentration by addition of equimolar stock 
solutions of gallium nitrate and ligand. The pH of the solutions was adjusted with DCl and 
CO2 free NaOD and measured with a Crison MicropH 2002 pH meter, equipped with an 
Ingold 405-M5 combined electrode.  
4.4. Imaging and activity counting 
A gamma camera-computer system (Maxicamera Digital GE 400 AC -camera, from 
General Electric, Milwaukee, WI, USA) was used for acquisition and pre-processing of the 
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in vivo gamma images, controlled by a Starport computer. Data processing and display 
were performed on a personal computer using homemade software developed for the IDL 
6.3 (Interactive Data Language, Research Systems, Boulder, CO, USA) computer tool. For 
measuring the in vitro activity of the organs a DPC-Gamma C12 gamma counter, coupled 
to a Compaq DeskPro computer was used. 
4.5. In vivo studies  
For the in vivo and in vitro studies the radiochelates were prepared by mixing the ligand 
solutions in 0.1 M HEPES with [67Ga](citrate) and heating at 95 ºC for 30 minutes. The 
gallium-67 source was gallium citrate. Finally the solution pH was adjusted to 7 with 
NaOH. Two groups of three Wistar rats (males) weighing approximately 300 g (one group 
for each chelate) were anaesthetized with Ketamine/Diazepam in a 4:1 proportion and 
injected in the femoral vein with circa 110 Ci of [67Ga](NOA2P)2- or [67Ga](NO2A2P)-. 
The animals were then positioned in ventral decubitus over the detector. Image acquisition 
was initiated immediately before radiotracer injection. Sequences of 180 images (of 10 s 
each) were acquired to 64 x 64 matrices. Images were subsequently processed using a 
homemade IDL based program. In order to analyse the transport of radiotracer over time, 
three regions of interest (ROI) were drawn on the image files, corresponding to the thorax, 
liver, and left kidney. From these ROI, time-activity curves were obtained. In addition, 
static data were acquired at 24 and 48 h after the radiotracer injection. 
4.6. Biodistribution studies. 
Two groups of four anaesthetized animals were injected with circa 110 Ci of each [67Ga] 
chelate. The animals were sacrificed 2 h and 48 h after injection and the major organs were 
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Figure 1. Chemical structures and atoms numbering scheme used for the proton NMR 













Figure 2. pH-potentiometric titration curve of a solution containing 3.968 mM NOA2P in 
the presence of 3.938 mM Ga3+ (I=0.1 M KCl, T=25 ºC). The Ga3+ was introduced in the 




































Figure 3. 31P NMR pH titration of NOA2P ligand (10 mM ligand concentration, Bruker 
Avance 360 MHz, T=25 oC, the ionic background was not controlled). Symbols indicate 
the measured data, the line is the fitted curve with log KH1 = 14.21 ± 0.09, log KH2 = 6.48 ± 

























Figure 4. 68Ga NMR spectra (left stack) and 31P NMR spectra (right stack) of 10 mM 
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Figure 5. pH distribution of GaNOA2P species vs pH calculated from thermodynamic data 
and concentrations of GaNOA2P complex (blue circles: signals for the complex) and free 











Figure 6.  In vivo biodistribution of the 67Ga3+ chelates of NOA2P (dark grey) and NO2AP 
(light grey) in Wistar rat tissues at 2 h after injection. Values are the mean of 4 animals. 
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Table 1. Stepwise protonation constants of various triaza macrocyclic ligands at 25 ºC. 
 
 NOTA NO2APa NOA2Pa NOTPa 
Log KH1 
 




14.21 ± 0.09d,l 
12.98 ± 0.10c 
15.2 ± 0.2d, 14.50 ± 0.01e 
(11.7f; 12.1g) 
 
Log KH2 5.59h; 5.74i;  
5.65j; 5.84k 
7.16 ± 0.05c 8.19 ± 0.35c 9.11 ± 0.03e  
(9.1f; 9.4g) 
Log KH3 2.88h; 3.16i;  
3.17j; 3.36k 
4.90 ± 0.08c 6.48 ± 0.09d  
6.29 ± 0.15c 
8.02 ± 0.03e  
(7.5f; 7.5g) 
Log KH4 1.98k 2.23± 0.12c 4.02 ± 0.09d  
4.24  ± 0.11c 
6.77 ± 0.03e   
(5.8f; 5.9g) 
Log KH5   2.1 ± 0.1d 
2.38 ± 0.13c 
5.56 ± 0.03e  
 (3.1f; 2.9g) 
Log KH6    3.45 ± 0.04e   
(2.9f) 
Log KH7    1.82 ± 0.03e 
a This work, literature data on NOTP in parenthesis; b from potentiometry, 0.1 M KCl; c from 1H NMR; d from 
31P NMR; e from 31P NMR using an H3PO4 external standard in a capillary; f from potentiometry, 0.1 M NaCl 
[26]; g from potentiometry, 0.1 M NMe4Cl [26]); h from potentiometry and 1H NMR, 0.1 M NaClO4 [27]; i 
from potentiometry, 0.1 M NaNO3 [28]; j from potentiometry, 0.1 M KCl [29]; k from potentiometry, 0.15 M 




























Table 2. Stability constant (log KGaL) of the Ga
3+ complex of NOA2P and its protonation 
constants (log KHiGaL and log KOHGaL) at 25 ºC in KCl 0.1 M in comparison with other Ga
3+ 
complexes (GaNOTA and GaDOTA). 
 
Species NOTAa, b NOA2P DOTA 
GaL 28.96a, 30.98b 34.44± 0.04 24.95a, 26.05c 
GaHL 1.75a, -b 4.98 ± 0.10 3.26a, 3.64c 
GaH2L - 2.76 ± 0.09 -a, 2.43c 
GaH3L - 1.61 ± 0.09 -a, 1.84c 
Ga(OH)L 10.30a, 9.70b 10.29 ± 0.03 - 
Ga(OH)2L - 11.33 ± 0.05 - 
a.Ref. [19]; b.Ref. [29]; c.Ref. [32].  
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Table 3. 71Ga NMR chemical shifts and linewidths for Ga3+ chelates of triazamacrocyclic 
ligands.  27Al NMR data for the corresponding Al3+ chelates are also shown when available 
(27Al shifts are relative to [Al(H2O)6]
3+). 
 
Ligand 71Ga  27Al  
  (ppm) ν1/2 (Hz)  (ppm) ν1/2 (Hz) 
H2O 0 53 0 3-20 
NOTA +171a 210a +49b 60b 
NO2AP +153c 914c   
NOA2P +130c 1528c   
NOTP +110d 434d +31.9b 205.5b 
DETA +133a 2000a +40.1e 100.2e 
UNTA not observedb not observedb   
DOTRA - 3500b   
NODASA +165f 1000f +47g 80g 
NOTMA +149h -   
NOTPP +132i 560i   
NOTBzP +130i 1220i   
NOTMP +136i 215i   
NOTAC6 +166j 622j +47.5j 54.9j 
NOTAC8 +166j 529j +47.3j 146.6j 




L1 +171k 235k   
L2 +175k 9085k   
L3 +141/186l 900/550l   







NOTA = 1,4,7-triazacyclononane-1,4,7-triacetic acid; DETA =  1,4,7-triazacyclodecane-1,4,7-triacetic acid; 
UNTA = 1,4,7-triazacycloundecane-1,4,7-triacetic acid ;DOTRA =  1,4,7-triazacyclododecane-1,4,7-triacetic 
acid; NODASA = 1,4,7-triazacyclononane-1-succinic acid-4,7-diacetic acid; NOTMA = (R)-1,4,7-tris(29-
methylcarboxymethyl)-triazacyclononane; NOTPP = 1,4,7-triazacyclononane-1,4,7-triyltrimethylenetris 
(phenylphosphinicacid); NOTBzP = 1,4,7-triazacyclononane-1,4,7-triyltrimethylenetris(benzylphosphinic 
acid); NOTMP = 1,4,7-triazacyclononane-1,4,7-triyltrimethylenetris(methylphosphinic acid); NOTAC6 = 
1,4,7-triazacyclononane-1-hexanoic acid-4,7-diacetic acid; NOTAC8 = 1,4,7-triazacyclononane-1-octanoic 
acid-4,7-diacetic acid; NOTAC16 = 1,4,7-triazacyclononane-1-hexadecanoic acid-4,7-diacetic acid; L1 = 
NO2A-N-methylacetamide; L2 = NO2A-N-benzylacetamide; L3 = 1,4,7-triazacyclononane-1- 
aminocarboxyethyl - 4,7-diacetic acid; L4 = 1,4,7-triazacyclononane-1- benzamidocarboxyethyl - 4,7-diacetic 
acid; TRAP-H =  1,4,7-triazacyclononane-1,4,7-tris(methylenephosphinicacid); a [11, 12]; b [21]; c This work; 
d [20]; eUnpublished results; f 68Ga signal [14]; g [15]; h[34]; i [16]; j [23]; k[35]; l [25]; m [19]. 
 
